Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6ATAC39P (RNA, U6atac small nuclear 39, pseudogene) is a non-functional, noncoding RNA element classified as a pseudogene. Pseudogenes like RNU6ATAC39P resemble functional genes—in this case, a member of the U6atac small nuclear RNA family—but lack the ability to produce functional protein or RNA products due to mutations or truncation[7][1][5]. U6atac snRNA, the likely parent gene, is normally involved in minor spliceosome-mediated pre-mRNA splicing, but as a pseudogene, RNU6ATAC39P does not participate in such functions. There are no known therapeutic drugs, biomarker applications, or direct disease associations for this pseudogene. It is not considered a therapeutic target nor a functional gene, but is notable as a marker of retrotransposition dynamics within the genome, a process involving the integration of noncoding RNA through LINE-1 machinery[3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 39, pseudogene (RNU6ATAC39P).